Dynavax Technologies Corporation
DVAX
Mkt cap
$1.82B
EV/Sales
6.22
P/E ratio
N/A
FY2024 Revenue
$277.25M
EPS (TTM)
$-0.37
Gross Margin (FY2024)
N/A
Profit Margin (FY2024)
9.85%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
Use this DVAX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full DVAX income, balance, and cash tables.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Dynavax Technologies Corporation (DVAX) revenue for Dec 31, 2024 was $277.2M. Net income was $27.3M. Statements: https://lician.com/financials/dvax
Dynavax Technologies Corporation (DVAX) market capitalization is $1.82B on the latest cached snapshot.